More Argent Biopharma Ltd news
Argent Biopharma LtdASX: RGT

MGC pharma executes US$24M US supply agreement

Aug 26, 2021 at 10:25 PM EDT · Issued by Argent Biopharma Ltd

Filed with ASX · Aug 26, 2021 at 10:25 PM EDT · 5 pages · English

On 6ix: 6ix.com/news/mgc-pharma-executes-usdollar24m-us-supply-agreement

Argent Biopharma Ltd on 6ix

Earlier from Argent Biopharma

  • Patent application lodged for novel drug delivery systemJul 15, 2021
  • 1St patient recruited into CimetrA phase 3 clinical trialJul 12, 2021
  • CannEpil available for free dispensing in irelandJun 14, 2021
  • MGC pharma 2021 clinical trials program updateMay 24, 2021
  • CimetrA patent submitted to European IP officeMay 17, 2021

Later from Argent Biopharma

  • Cimetra import approval granted for indiaSep 3, 2021
  • UK import permit granted for CannEpilSep 13, 2021
  • ArtemiC eu sale approval and clinical trial updateSep 15, 2021
  • First order received under US supply agreementSep 29, 2021
  • AMC inc. places US$3M CimetrA purchase orderOct 6, 2021
All Argent Biopharma news releases↗

Follow Argent Biopharma into a list and get an email when it puts out news.

Follow Argent Biopharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer